Safer pharmaceutical-grade alternatives to toxic and unregulated supplies of opioids could help address opioid diversion issues for patients to better prevent overdoses and other harms linked to the toxic drug supply.
A team of investigators, led by Michelle Olding, PhD, of the Division of Social and Behavioural Health Sciences in the Dalla Lana School of Public Health at the University of Toronto, examined patient and provider perspectives on the diversion of opioids prescribed in safer supply